Clinical Trials at Northern Westchester Hospital
As of September 2026, 21 paid clinical trials are recruiting at Northern Westchester Hospital, located at 400 E MAIN ST, NORTHERN WESTCHESTER HOSPITAL, MOUNT KISCO, NY 10549-3417, phone (914) 666-1200 in Mount Kisco, New York. Active studies at this site cover conditions such as Major Depressive Disorder, Anatomic Stage II Breast Cancer AJCC v8 and Advanced Esophageal Adenocarcinoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
21 clinical trials at Northern Westchester Hospital
·Clear filters·A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Common conditions studied in Mount Kisco
- Major Depressive Disorder (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Advanced Esophageal Adenocarcinoma (2 active studies)
- Advanced Gastric Adenocarcinoma (2 active studies)
- Advanced Gastroesophageal Junction Adenocarcinoma (2 active studies)
- Binge-Eating Disorder (2 active studies)
Leading research sponsors in Mount Kisco
- Alliance for Clinical Trials in Oncology
- NRG Oncology
- Axsome Therapeutics, Inc.
- National Cancer Institute (NCI)
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Mount Kisco?
There are approximately 44 recruiting clinical trials in Mount Kisco, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Mount Kisco pay participants?
Most recruiting trials in Mount Kisco compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Mount Kisco?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Mount Kisco?
The most common conditions under active study in Mount Kisco include Major Depressive Disorder (6), Anatomic Stage II Breast Cancer AJCC v8 (3), Advanced Esophageal Adenocarcinoma (2), Advanced Gastric Adenocarcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Mount Kisco?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Mount Kisco on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Mount Kisco?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Mount Kisco?
Recruiting research sites in Mount Kisco include Northern Westchester Hospital, Bioscience Research LLC, Neurocrine Clinical Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Mount Kisco right now?
The largest active categories in Mount Kisco are Cancer & tumors (17), Cardiovascular (3), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Northern Westchester Hospital?
Northern Westchester Hospital is located at 400 E MAIN ST, NORTHERN WESTCHESTER HOSPITAL, MOUNT KISCO, NY 10549-3417. Use the Google Maps link in the intro above to get directions.
How do I contact Northern Westchester Hospital?
You can reach Northern Westchester Hospital by phone at (914) 666-1200. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.